Torrent Pharmaceuticals: Riding the Wave of Revenue Growth

Torrent Pharmaceuticals reported a 20% year-on-year increase in net profit to Rs 548 crore for the June quarter, driven by strong sales across various markets. The company's revenue from operations rose to Rs 3,178 crore, with significant growth in India, the US, Brazil, and Germany.


Devdiscourse News Desk | New Delhi | Updated: 28-07-2025 17:33 IST | Created: 28-07-2025 17:33 IST
Torrent Pharmaceuticals: Riding the Wave of Revenue Growth
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

Torrent Pharmaceuticals announced a significant 20% increase in its consolidated net profit for the June quarter, a rise that brought the total to Rs 548 crore compared to the same period last year.

The pharmaceutical giant noted a strong performance was aided by its key markets, particularly India and the US, which contributed to the robust revenue of Rs 3,178 crore.

Markets such as Brazil and Germany also played crucial roles, posting revenue increases of 11% and 9%, respectively, reflecting the company's strategic focus on growth therapies.

(With inputs from agencies.)

Give Feedback